ABG Lab announces new distributor

ABG Lab has announced that it has added UK wholesaler and distributor Rosmetics Aesthetics to its global distributor portfolio.

The company will distribute ABG Lab’s range of regenerative therapy intradermal injectables to medical aesthetics businesses across the UK.

“The aesthetics market continues to be a pioneering space that leads the way in scientific progression and innovation,” said Dr Elina Tester, president and chief executive of ABG Lab. 

“ABG Lab has a history of developing cutting-edge skincare technologies and intradermal injectables. This next phase is an exciting time for the company, paving the way for new products in 2023, and we are thrilled to be working with Rosmetics to grow our UK business over the coming months.”

Neal Bryant, chief business development officer of ABG Lab, commented on the new contract “Rosmetics is a well-established, well-connected UK distributor whose knowledge and experience of the UK aesthetics market is extensive. We look forward to working with them to grow and establish a network of clinic partners for our pioneering range of safe and highly effective regenerative therapy intradermal injectables here in the UK.”

Ros Brown, chief executive and founder of Rosmetics shared their enthusiasm: “We are delighted to have been appointed as ABG Lab’s first UK distributor. As a business who has a long history in the aesthetics industry, and as a practitioner who works with some of the very best products in the industry, it’s important for us to work with products that we truly believe in, and that are safe, effective and produce outstanding results for patients. ABG Lab’s range of intradermal injectables are state-of-the-art in development and design and fit well with our ethos of bringing the very best in the industry to clinics across the UK.”

Professionals wishing to find out more about ABG Lab’s range of regenerative therapy intradermal injectables should contact info@rosmetics.co.uk.